Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Entera Bio Ltd. - Ordinary Shares (NQ:ENTX)

2.625 -0.145 (-5.23%)
Delayed Quote Updated: 9:54 AM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Entera Bio Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement ↗
Entera Bio (NASDAQ:ENTX) plans to begin a Phase 3 study of its oral osteoporosis candidate EB613 after reaching agreement with the U.S. Food and Drug Administration on a 12-month, placebo-controlled... 
Via MarketBeat
Entera Bio (NASDAQ:ENTX) Slides on Wider Q2 Loss Despite FDA Phase 3 Alignment and $275M Cash Raise ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Entera Bio: Q1 Earnings Insights ↗
 
Via Benzinga
Curious about the most active stocks on Monday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular session. The company's market cap stands at $100.9 million. Gossamer Bio (NASDAQ:GOSS) shares moved... 
Via Benzinga
Monday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-06-22: top gainers and losers in today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
ENTX Rallies As Insiders Buy Company Shares — Retail Hopes For ‘Exciting Days’ Ahead ↗
Entera Bio said that the company chairman Geno J. Germano bought shares, in addition to directors Steven D. Rubin, Haya Taitel, and Sean Ellis. 
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Entera Bio Beats Q2 EPS Estimates ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
ENTX Stock Earnings: Entera Bio Meets EPS for Q2 2024 ↗
ENTX stock results show that Entera Bio met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years ↗
These are the meme stocks to buy as they represent fundamentally strong ideas with major growth acceleration catalysts. 
Via InvestorPlace
News headline image
3 Meme Stocks That Can Surge by 200% Before 2025 ↗
Don't wait too long on these attractive meme stocks to buy for 200% upside, as they represent good businesses with growth catalysts. 
Via InvestorPlace
News headline image
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns ↗
These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline. 
Via InvestorPlace
News headline image
3 Meme Stocks to Buy on the Dip: June 2024 ↗
Investors can't miss out on meme stocks to buy on the dip since these represent fundamentally sound ideas with growth acceleration catalysts 
Via InvestorPlace
News headline image
7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months ↗
Wise investors consider penny stocks to buy which represent companies with vigorous fundamentals and a robust growth outlook. 
Via InvestorPlace
News headline image
Rag to Riches: 3 Penny Stocks That Could Make Early Investors Rich ↗
These are the penny stocks to buy, representing businesses with a promising growth outlook for the long term. 
Via InvestorPlace
News headline image
3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024 ↗
These are undervalued penny stocks to buy as they represent companies with the likelihood of multi-fold growth in revenue. 
Via InvestorPlace
News headline image
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 ↗
These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news 
Via InvestorPlace
News headline image
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar ↗
These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials. 
Via InvestorPlace
News headline image
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom ↗
These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress. 
Via InvestorPlace
News headline image
ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024 ↗
ENTX stock results show that Entera Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? ↗
Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year. 
Via InvestorPlace
News headline image
Entera Bio And 3 Other Stocks Under $1 Insiders Are Buying ↗
The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Topics Stocks
News headline image
Bioventus And 3 Other Stocks Under $5 Insiders Are Buying ↗
The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
Via Benzinga
Topics Stocks
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.